KRT18 and metabolic dysfunction-associated steatohepatitis: Likewise, circulating cytokeratin-18 levels (not EV-associated) were also found to be increased in patients with NASH (n = 41) compared to in patients without NASH (n = 54) and could be applied diagnostically (AUROC = 0.86) [70].